Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Early diagnosis and tailored treatment are crucial to prevent permanent hair loss and support self-esteem in children with scarring alopecia.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

No cure exists for alopecia areata; treatments aim to manage symptoms.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A tailored treatment improved a Pomeranian dog's skin and hair issues caused by a vaccine.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

Treating underlying conditions and using antifungals effectively resolve Pityrosporum folliculitis in immunocompromised people.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

Transplant patients often get skin problems, with treatments varying by condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Effective symptom management in IBD improves quality of life and prevents complications.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.